LNA Sante SA risk profile
37 Normal where most of the sector sits
Measured 1 September 2026 from LNA's filed statements. Recomputed nightly.
37 (Normal), driven by Leverage and coverage at 63, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 33 | Normal | Stable | One-year price volatility — 27.5% |
| Operating pressure | 41 | Elevated | Worsening | Costs outgrowing revenue — +0.2 percentage points |
| Cash conversion | 16 | Contained | Worsening | Capital spending against operating cash — 0.13x |
| Leverage and coverage | 63 | Stretched | Stable | Net debt to EBITDA — 5.28x |
| Competitive position | 33 | Normal | Stable | Revenue-growth gap against peers — -4.3 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.